Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials

Leukemia. 2016 Jul;30(7):1593-6. doi: 10.1038/leu.2015.352. Epub 2015 Dec 21.

¹ Charité, Campus Virchow Klinikum, Medizinische Klinik m.S. Hämatologie und Onkologie, Universitätsmedizin Berlin, Berlin, Germany.
² Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Department of Haematology, SA Pathology, University of Adelaide, Adelaide, South Australia, Australia.
³ Centre Hospitalier Universitaire de Bordeaux, Laboratoire d'Hématologie et Service des Maladies du Sang, Bordeaux et Institut Bergonié, Bordeaux, France.
⁴ Division of Hematology, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
⁵ Department of Hematology and IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain.
⁶ Department of Medicine, Division of Hematology/Oncology, University of California at San Francisco School of Medicine, San Francisco, CA, USA.
⁷ Bristol-Myers Squibb, Princeton, NJ, USA.
⁸ Division of Cancer Medicine, Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Publication types